comparemela.com

Page 14 - Axsm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Axsome Therapeutics, Inc (NASDAQ:AXSM) Given Consensus Rating of Buy by Analysts

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) has been given an average recommendation of “Buy” by the twelve brokerages that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and eight have given a buy recommendation to the company. The average […]

United statesGeode capital managementAxsome therapeutics incFairmount funds managementZacks investment researchBlackrock incBellevue groupVanguard group incJefferies financial groupAxsome therapeuticsGet ratingFinancial groupInvestment researchFunds managementCapital managementNasdaq axsm

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Axsome

NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Axsome.

New yorkUnited statesLaurence rosenPhillip kimChinese companyAxsome therapeutics incDrug administrationSecurities class action servicesRosen law firmAxsome therapeuticsClass periodLaw firmClass action servicesDrug applicationClass has beenThe rosen law firm pa

AXSM Shareholder News: Robbins LLP Reminds Investors of

SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class.

Aaron dumasAxsome therapeutics incSecurities exchangeDrug administrationAxsome therapeuticsSecurities exchange actCase aboutMade misleading statementsNew drug applicationAcute treatmentComplete response letterPrescription drug user fee actRobbins llpXsm shareholdersXsm class actionXsm lawsuit

DEADLINE ALERT for FHS, OSCR, UPST, and AXSM: The Law

LOS ANGELES, May 20, 2022 (GLOBE NEWSWIRE) The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of.

United statesLos angelesFrankr cruzSchool educationHoldings incAxsome therapeutics incSchool education group co ltdOscar health incLaw officesPlaintiff deadlineTwo sessionsFirst high school educationRegistration statementRisk adjustment data validationClass periodAttorney advertising

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Axsome

NEW YORK, May 20, 2022 (GLOBE NEWSWIRE) WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on.

New yorkUnited statesLaurence rosenPhillip kimChinese companyAxsome therapeutics incDrug administrationSecurities class action servicesRosen law firmAxsome therapeuticsClass periodLaw firmClass action servicesDrug applicationClass has beenThe rosen law firm pa

vimarsana © 2020. All Rights Reserved.